James L. Rogers

Array ( [id] => 8542886 [patent_doc_number] => 08318172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Breaking immunological tolerance with a genetically encoded unnatural amino acid' [patent_app_type] => utility [patent_app_number] => 12/322938 [patent_app_country] => US [patent_app_date] => 2009-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 36 [patent_no_of_words] => 53843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12322938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385130 [patent_doc_number] => 20090226374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'ANAPHYLATOXINS FOR DETECTING CLINICAL CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/356423 [patent_app_country] => US [patent_app_date] => 2009-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11248 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226374.pdf [firstpage_image] =>[orig_patent_app_number] => 12356423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834315 [patent_doc_number] => 08450070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Method for screening of cell-protecting agent' [patent_app_type] => utility [patent_app_number] => 12/810585 [patent_app_country] => US [patent_app_date] => 2008-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 25550 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12810585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5532949 [patent_doc_number] => 20090232737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Purification of proteins' [patent_app_type] => utility [patent_app_number] => 12/316708 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17807 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232737.pdf [firstpage_image] =>[orig_patent_app_number] => 12316708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431037 [patent_doc_number] => 20100143364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/329295 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18374 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143364.pdf [firstpage_image] =>[orig_patent_app_number] => 12329295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352580 [patent_doc_number] => 20100249384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'IMMUNOGLOBULIN AGGREGATES' [patent_app_type] => utility [patent_app_number] => 12/744089 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7410 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249384.pdf [firstpage_image] =>[orig_patent_app_number] => 12744089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575512 [patent_doc_number] => 20100129414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment' [patent_app_type] => utility [patent_app_number] => 12/276995 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7072 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129414.pdf [firstpage_image] =>[orig_patent_app_number] => 12276995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232369 [patent_doc_number] => 08197809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'CD9-specific human antibodies' [patent_app_type] => utility [patent_app_number] => 12/523516 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15133 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/197/08197809.pdf [firstpage_image] =>[orig_patent_app_number] => 12523516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6049045 [patent_doc_number] => 20110207916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Dual Affinity Polypeptides for Purification' [patent_app_type] => utility [patent_app_number] => 12/740940 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22893 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207916.pdf [firstpage_image] =>[orig_patent_app_number] => 12740940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580529 [patent_doc_number] => 20090175875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Molecules and Methods for Modulating Complement Component' [patent_app_type] => utility [patent_app_number] => 12/263909 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25864 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175875.pdf [firstpage_image] =>[orig_patent_app_number] => 12263909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502217 [patent_doc_number] => 20110263826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'ANTIBODIES WHICH BIND SELECTIVELY TO HAIR OF ANIMALS AND AN ANTIBODY BASED DRUG DELIVERY SYSTEM FOR ANIMALS' [patent_app_type] => utility [patent_app_number] => 12/741036 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9087 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263826.pdf [firstpage_image] =>[orig_patent_app_number] => 12741036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958491 [patent_doc_number] => 20110182878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Anti-Ricin Antibody' [patent_app_type] => utility [patent_app_number] => 12/682208 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6834 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182878.pdf [firstpage_image] =>[orig_patent_app_number] => 12682208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6646142 [patent_doc_number] => 20100228010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METHOD FOR PURIFYING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/681189 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14084 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20100228010.pdf [firstpage_image] =>[orig_patent_app_number] => 12681189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613344 [patent_doc_number] => 20100310458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'USE OF SOLUBLE CEACAM8 FOR DIAGNOSING, TREATING OR MONITORING DISEASES, AND A METHOD FOR SCREENING COMPOUNDS THAT PREVENT APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/680716 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12735 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310458.pdf [firstpage_image] =>[orig_patent_app_number] => 12680716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270974 [patent_doc_number] => 20090074750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'REGULATOR OF BASAL CELLULAR CALCIUM CONCENTRATION AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/210985 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20951 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074750.pdf [firstpage_image] =>[orig_patent_app_number] => 12210985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577901 [patent_doc_number] => 08344111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Human monoclonal nicotine specific antibodies' [patent_app_type] => utility [patent_app_number] => 12/745537 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26607 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323316 [patent_doc_number] => 20100196927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHOD OF DETERMINING FUNCTIONAL DEFICIENCIES IN THE COMPLEMENT SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/676283 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8852 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196927.pdf [firstpage_image] =>[orig_patent_app_number] => 12676283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6265068 [patent_doc_number] => 20100297697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHODS FOR INCREASING PROTEIN TITERS' [patent_app_type] => utility [patent_app_number] => 12/675218 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14581 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297697.pdf [firstpage_image] =>[orig_patent_app_number] => 12675218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9923096 [patent_doc_number] => 08981060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Method of inhibiting complement activation with factor Bb specific antibodies' [patent_app_type] => utility [patent_app_number] => 12/675220 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 37 [patent_no_of_words] => 17030 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320510 [patent_doc_number] => 20100196374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/452772 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11828 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196374.pdf [firstpage_image] =>[orig_patent_app_number] => 12452772 [rel_patent_id] =>[rel_patent_doc_number] =>)